The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
 
Beate Schultheis
No Relationships to Disclose
 
Dirk Strumberg
Research Funding - Silence Therapeutics
 
Jan Kuhlmann
No Relationships to Disclose
 
Martin Wolf
No Relationships to Disclose
 
Karin Link
No Relationships to Disclose
 
Thomas Seufferlein
Honoraria - Amgen; Bayer Schering Pharma; Celgene; Falk Foundation; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merck Serono
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Bayer Schering Pharma; Celgene; Merck Serono; Roche; Sanofi
 
Joerg Kaufmann
Employment - Silence Therapeutics
Stock and Other Ownership Interests - Silence Therapeutics
 
Frank Gebhardt
Employment - Silence Therapeutics
Stock and Other Ownership Interests - Silence Therapeutics
 
Nico Bruyniks
Employment - Silence Therapeutics
 
Uwe Pelzer
No Relationships to Disclose